In vitro tobramycin elution analysis from a novel β-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 70, Issue 1, 2004, Pages 1-20

  DiCicco, Michael ^a   Goldfinger, Aaron ^a   Guirand, Felix ^b   Abdullah, Aquill ^b   Jansen, Susan A ^a  

^a Temple University   (United States)

^b Library Access Services Librarian   (United States)

Author keywords

Drug delivery system; Fluorescence; Silicate xerogel; Tobramycin; tricalcium phosphate

Indexed keywords

BIODEGRADATION; BONE; COMPLEXATION; IMPREGNATION; ION IMPLANTATION; KINETIC THEORY; OPTIMIZATION; POROSITY; SALTS; SILICATES;

ELUTION RATE CONSTANTS; HIGH POLAR SALTS; SILICATE XEROGELS; TOBRAMYCIN;

BIOMEDICAL ENGINEERING;

CALCIUM PHOSPHATE; HYDROXYAPATITE; SILICATE; SULFATE; TOBRAMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIODEGRADABILITY; BONE PROSTHESIS; DERIVATIZATION; DEVICE; DRUG DELIVERY SYSTEM; DRUG HYDROLYSIS; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; ELUTION; ENCAPSULATION; ESTERIFICATION; FLUORESCENCE; GELATION; HYDROPHILICITY; ION EXCHANGE; POROSITY; SCANNING ELECTRON MICROSCOPY;

EID: 3042805196     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30014     Document Type: Article

References (74)

1. Available: http://www.opm.gov/feddata/retire/projections.asp.
2. Goldfinger A. Silicate glass: A novel drug delivery system [thesis]. Philadelphia: Temple University; 2000.
3. Vasquez M. Osteomyelitis in children. Curr Opinion Pediatr 2002;14:112-115.
4. Sasaki S, Ishii Y. Apatite cement containing antibiotics: Efficacy in treating experimental osteomyelitis. J Orthop Sci 1999; 4:361-369.
5. van de Belt H, Neut D, Uges DRA, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Surface roughness, porosity, and wettability of Gentamycin-loaded bone cements and their antibiotic release. Biomaterials 2000;21:1981-1987.
6. Richelsoph KC, Petersen DW, Haggard WO, Grisoni BF, Morris LH. Elution characteristics of tobramycin-impregnated medical grade calcium sulfate hemihydrate. In: 44th Annual Meeting, ORS; 1998 March 16-19; New Orleans, LA.
7. Poelestra KA, Busscher HJ, Schenk W, van Horn JR, van der Mei HC. Effect of Gentamycin loaded PMMA bone cement on Staphylococcus aureus biofilm formation. Biofouling 1999;14: 249-254.
8. Thomazeau H, Langlais F. Antibiotic release by tricalcic phosphate bone implantation. In vitro and in vivo pharmacokinetics of different galenic forms. Chirurgie 1997;121:663-666.
9. Cornell CN, Tyndall D, Waller S, Lane JM, Brause BD. Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute. J Orthop Res 1993;11:619-626.
10. Shinto Y, Uchida A, Koskusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 1992;74:600-604.
11. Thoma K, Alex R, Randzio J. Biodegradable Gentamycin-depot implants made of β-tricalcium phosphate ceramics. III. In vivo studies on drug release, tissue tolerance, and biodegradation. Pharmazie 1991;46:266-270.
12. Buchholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 1970;41:511-515.
13. Mitsuhashi Y, Susumu K. Drug action and drug resistance in bacteria. Tokyo: University of Tokyo Press; 1975.
14. Penner MJ, Duncan CP, Masri BA. The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. J Arthroplasty, 1999;14:209-214.
15. Greene N, Holtom PD, Warren CA, Ressler RL, Sheperd L, McPherson EJ, Patzakis MJ. In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. Am J Orthop 1998;27:201-205.
16. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: Biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999;14:339-346.
17. Information for Health Professionals Data Sheet. - Tobramycin sulfate. Available: http://www.medsafe.govt.nz/Profs/datasheet/n/nebcininj.html. Accessed 2000.
18. Clinical Pharmacology Online. Tobramycin. Available: http://www.rxlist. com
19. Tobramycin Material Safety and Data Sheet. Available: http://www.hazard.com/msds/index.php
20. Stemberger A, Grimm H, Bader F. Local treatment of bone and soft tissue infections with the collagen-gentamycin sponge. Eur J Surg 1997;578(Suppl):17- 26.
21. Rutten HJT, Nijuis PHA. Prevention of wound infection in elective colorectal surgery by local application of a Gentamycin-cotaining collagen sponge. Eur J Surg 1997;578(Suppl):31-35.
22. Otsuka M, Sawada M, Matsuda Y, Nakamura T, Kokubo T. Antibiotic delivery system using bioactive cement consisting of Bis-GMA/TEGDMA resin and bioactive glass ceramics. Biomaterials 1997;18:1559-1564.
23. Kawanabe K, Okada Y, Matsusue Y. Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg Br 1998;80:527-530.
24. Netz DJA, Sepulveda P, Pandofelli VC, Spadaro ACC, Alencastre JB, Bentley MLVB, Marchetti JM. Potential use of gel casting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm 2001;213:177-125.
25. Itokazu M, Ohno T, Tanemori T. Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats. J Med Microbiol 1997;46:779-783.
26. Queiroz AC, Santos JD, Monteiro FJ, Gibson IR, Knowles JC. Adsorption and release studies of sodium ampicillin from hydroxyapatite and glass-reinforced hydroxyapatite composites. Biomaterial 2001;22:1393-1400.
27. Yaylaoglu MB, Koskusuz F, Hasirei V. In: Haris PI, Chapman D, editors. New biomedical materials. Amsterdam: IOS Press; 1998. p 149-154.
28. Bohner M, Lemaitre J, Merkle HP, Gander B. Control of Gentamycin release from a calcium phosphate cement by admixed poly(acrylic acid). J Pharm Sci 2000;89:1262-1270.
29. Bohner M, Lemaitre J, van Landyut P, Zambelli PY, Merkle HP, Gander B. Gentamycin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci 1997; 86:565-572.
30. Thoma K, Alex R, Fensch-Kleemann E. Biodegradable controlled-release implants based on β-tricalcium phosphate ceramic. Part 1. Preparation and characterization of porous β-tricalcium phosphate pellets. Eur J Pharm Biopharm 1992;38: 101-106.
31. Thoma K, Alex R, Randzio J. Biodegradable controlled-release implants based on β-tricalcium phosphate ceramic. Part 2. Testing of Gentamycin controlled-release pellets in-vitro and invivo. Eur J Pharm Biopharm 1992;38:107-112.
32. Garvin KL, Miyano JA, Robinson D. Polylactide/polyglycolide antibiotics implants in the treatment of osteomyelitis. J Bone Joint Surg 1994;76A:1500-1506.
33. Tsourvakas S, Hatzigrigorig P, Tsibinos A. Pharmacokinetic study of fibrin clot-ciprofloxacin complex: An in vitro and in vivo experimental investigation. Arch Orthop Trauma Surg 1995;144:295-297.
34. Schreirholz JM, Steinhauser H, Rump AFE. Controlled release of antibiotics from biomedical polyurethanes: Morphological and structural features. Biomaterials 1997;18:839-844.
35. Vaccaro RA. The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics 2002;25:S572-S578.
36. Kortesuo P, Ahola M, Kangas M, Leino T, Laasko S, Vuorilehto L, Yli-Urpo A, Kiesvaara J, Marvola M. Alkyl-substituted silica gel as a carrier in the controlled release of dexmedetomidine. J Control Rel 2001;76:227-238.
37. Kortesuo P, Ahola M, Karlsson S, Kangasniemi I, Kiesvaara J, Yli-Urpo A. Sol-gel-processed sintered xerogel as a carrier in controlled drug delivery. J Biomed Mater Res 1999;44:162-167.
38. Kortesuo P, Ahola M, Kangas M, Yli-Urpo A, Kiesvaara J, Marvola M. In vitro release of dexmedetomidine from silica xerogel monoliths: Effect of sol-gel synthesis parameters. Int J Pharm 2001;221:107-114.
39. Kortesuo P, Ahola M, Kangas M, Kangasniemi I, Yli-Urpo A, Kiesvaara J. In vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery. Int J Pharm 2000;200:223-229.
40. Radin S, Ducheyne P, Kamplain T, Tan BH. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res 2001;57:313-320.
41. Aughenbaugh W, Radin S, Ducheyne P. Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vancomycin. J Biomed Mater Res 2001;57:321-326.
42. Ahola MS, Sailynoja ES, Raitavuo MH, Vaahtio MM, Salonen JI, Yli-Urpo AUO. In vitro release of heparin from silica xerogels. Biomaterials 2001;22:2163-2170.
43. Kanellakopoulou K, Glamerellos-Bourbolis EJ. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 2000;59:1223-1232.
44. Atkins B, Gottleib T. Fusidic acid in and joint infections. Int J Antimicrob Agents 1999;12(2 Suppl):S79-S93.
45. Suwanprateeb J, Tanner K, Turner W. Influence of sterilization by gamma irradiation of thermal annealing on creep of hydroxy-apatite-reinforced polyethylene composites. J Biomed Mater Res 1998;39:16-22.
46. Assink RA, Kay BD. Sol-gel kinetics by NMR. Polymer Prepr Am Chem Soc Div Polym Chem 1991;32:506-507.
47. Szpalski M, Gunzburg R. Applications of calcium phosphate-based cancellous bone void fillers in trauma surgery. Orthopedics 2002;25(5 Suppl):S601-S609.
48. Bohner M. Calcium orthophosphates in medicine: From ceramic to calcium phosphates cements. Injury 2000;31(4 Suppl): SD37-SD47.
49. Available at http://www.orthovita.com/products/vitoss/index.html.
50. 2 powders. Indian J Technol 1987; 25:282-289.
51. 2 hybrid sol-gel materials. J Mater Res 1993;8;1143-1152.
52. D-glucose-templated mesoporous silica sol-gel materials. Chem Mater 1999;11:2023-2029.
53. Wei Y, Bakthavatchalam R, Yang D, Whitecar CK. Synthesis and characterization of polyacrylate-inorganic hybrid materials via the sol-gel approach. Polym Prepr Am Chem Soc Div Polym Chem 1991;32:503-505.
54. Marsical R, Lopez-Granados M, Fierro JLG, Sotelo JL, Martos C., Van Greiken R. Morphological and surface properties of titania-silica hydrophobic xerogels Langmuir 2000;16:9460-9467.
55. Perdroso MAS, Dias ML, Azuma C, Mothe CG. Hydrocarbon dispersion of nanospherical silica by a sol-gel process. 1. Tetraethoxysilane homopolymerization. Colloid Polym Sci 2000; 278:1180-1186.
56. 2O. Am Mineral 1955;40:147-178.
57. Chan CK, Peng SL, Chu IM, Ni SC. Effects of heat treatment on the properties of poly(methyl methacrylate)/silica hybrid materials prepared by sol-gel process. Polymer 2001;42:4189-4196.
58. You WW, Haugland RP, Ryan DK, Haugland RP. 2-(4-Carboxybenzoyl) quinoline-2-carboxyaldehyde, a reagent with broad dynamic range for the assay of proteins and lipoproteins in solution Analyt Biochem 1997;244:277-282.
59. Molecular probes product fact sheet, CBQCA. Available: http://www.molecularprobes.com.
60. Zhang Y, Arriaga E, Diedrich P, Hindsgaul O, Dovichi NJ. Nanomolar determination of aminated sugars by capillary electrophoresis. J Chromatogr A 1995;716:221-229.
61. El-Shabrawy Y. Fluorometric determination of aminoglycoside antibiotics in pharmaceutical preparations and biological fluids. Spectrosc Lett 2002;35:99-109.
62. Ragel CV, Vallet-Regi M. In vitro bioactivity and Gentamycin release from glass-polymer-antibiotic composites. J Biomed Mater Res 2000;51:424-429.
63. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-1149.
64. Laidler KJ, editor. Chemical kinetics. New York: Harper Collins; 1987.
65. Baker AS, Greenham LW. Release of Gentamycin from acrylic bone cement. J Bone Joint Surg Am 1988;70:1551-1557.
66. Kuechle DK, Landon GC, Musher DM, Noble PC. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop 1991;264:302-308.
67. Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase negative staphylococci. J Bone Surg B 198971: 851-855.
68. DiCicco M, Duong T, Chu A, Jansen SA. Tobramycin and Gentamycin elution analysis between two in-situ polymerizable orthopaedic composites. J Biomed Mater Res Appl Biomater. Forthcoming.
69. Chohfi M, Langlais F, Fourastier J, Minet J, Thomazean H, Cormier M. Pharmacokinetics uses, and limitations of vancomycin-loaded bone cement. Int Orthop 1998;22:171-177.
70. Frutos Cabanillas P, Diez Pena E, Barrales-Rienda JM, Frutos G. Validation and in vitro characterization of antibiotic-loaded bone cement release. Int J Pharm 2000209:15-26.
71. Weisman DL, Olmstead ML, Kowalski JJ. In vitro evaluation and antibiotic elution from polymethylmethacrylate (PMMA) and mechanical assessment of antibiotic-PMMA composites. Vet Surg 2000;29:245-251.
72. Clineff TD. Bioactivity report: Determination of VITOSS bioactivity by assessing the formation of a superficial hydroxyapatite layer by FTIR. Unpublished internal report. Orthovita, Inc.
73. Greenspan DC. Developments in biocompatible glass compositions. Available: http://www.devicelink.com/mddi/archive/99/03/011.html
74. Ruys AJ. Silicon-doped hydroxyapatite. J Aust Ceram Soc 1993;29:71-80.